{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T14:31:36Z","timestamp":1789741896389,"version":"4.0.1"},"reference-count":34,"publisher":"Hindawi Limited","issue":"7","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":972,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Depress Anxiety"],"published-print":{"date-parts":[[2013,7]]},"DOI":"10.1002\/da.22047","type":"journal-article","created":{"date-parts":[[2013,1,3]],"date-time":"2013-01-03T07:13:55Z","timestamp":1357197235000},"page":"631-637","source":"Crossref","is-referenced-by-count":24,"title":["A HIGH-THROUGHPUT CLINICAL ASSAY FOR TESTING DRUG FACILITATION OF EXPOSURE THERAPY"],"prefix":"10.1155","volume":"30","author":[{"given":"Thomas L.","family":"Rodebaugh","sequence":"first","affiliation":[{"name":"The Anxiety and Psychotherapy Laboratory; Washington University; St. Louis; Missouri"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheri A.","family":"Levinson","sequence":"additional","affiliation":[{"name":"The Anxiety and Psychotherapy Laboratory; Washington University; St. Louis; Missouri"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric J.","family":"Lenze","sequence":"additional","affiliation":[{"name":"The Anxiety and Psychotherapy Laboratory; Washington University; St. Louis; Missouri"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"98","published-online":{"date-parts":[[2013,1,2]]},"reference":[{"issue":"4","key":"10.1002\/da.22047-BIB0001|da22047-cit-0001","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.biopsych.2006.03.084","article-title":"Effects of D-Cycloserine on extinction: translation from preclinical to clinical work","volume":"60","author":"Davis","year":"2006","journal-title":"Biol Psychiatry"},{"issue":"2","key":"10.1002\/da.22047-BIB0002|da22047-cit-0002","first-page":"75","article-title":"Combining D-Cycloserine and exposure-based CBT for the anxiety disorders","volume":"6","author":"Deveney","year":"2009","journal-title":"Clin Neuropsychiatry"},{"issue":"6","key":"10.1002\/da.22047-BIB0003|da22047-cit-0003","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.biopsych.2007.11.011","article-title":"A randomized controlled trial of D-Cycloserine enhancement of exposure therapy for social anxiety disorder","volume":"63","author":"Guastella","year":"2008","journal-title":"Biol Psychiatry"},{"issue":"12","key":"10.1002\/da.22047-BIB0004|da22047-cit-0004","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1016\/j.biopsych.2008.01.012","article-title":"A meta-analysis of D-Cycloserine and the facilitation of fear extinction and exposure therapy","volume":"63","author":"Norberg","year":"2008","journal-title":"Biol Psychiatry"},{"issue":"4","key":"10.1002\/da.22047-BIB0005|da22047-cit-0005","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.biopsych.2009.07.036","article-title":"Efficacy of D-Cycloserine for enhancing response to cognitive-behavior therapy for panic disorder","volume":"67","author":"Otto","year":"2010","journal-title":"Biol Psychiatry"},{"issue":"11","key":"10.1002\/da.22047-BIB0006|da22047-cit-0006","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1001\/archpsyc.61.11.1136","article-title":"Cognitive enhancers as adjuncts to psychotherapy: use of D-Cycloserine in phobic individuals to facilitate extinction of fear","volume":"61","author":"Ressler","year":"2004","journal-title":"Arch Gen Psychiatry"},{"issue":"3","key":"10.1002\/da.22047-BIB0007|da22047-cit-0007","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1001\/archpsyc.63.3.298","article-title":"Augmentation of exposure therapy with D-Cycloserine for social anxiety disorder","volume":"63","author":"Hofmann","year":"2006","journal-title":"Arch Gen Psychiatry"},{"issue":"8","key":"10.1002\/da.22047-BIB0008|da22047-cit-0008","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1038\/nrd1470","article-title":"Can the pharmaceutical industry reduce attrition rates? Nature reviews","volume":"3","author":"Kola","year":"2004","journal-title":"Drug Discov"},{"issue":"3","key":"10.1002\/da.22047-BIB0009|da22047-cit-0009","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/nrd3078","article-title":"How to improve R&D productivity: the pharmaceutical industry's grand challenge. Nature reviews","volume":"9","author":"Paul","year":"2010","journal-title":"Drug Discov"},{"key":"10.1002\/da.22047-BIB0010|da22047-cit-0010","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0005-7894(05)80088-7","article-title":"Social phobia: the role of in-situation safety behaviors in maintaining anxiety and negative beliefs","volume":"26","author":"Wells","year":"1995","journal-title":"Behav Ther"},{"issue":"3","key":"10.1002\/da.22047-BIB0011|da22047-cit-0011","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/S0005-7894(98)80037-3","article-title":"Social phobia: effects of external attention on anxiety, negative beliefs, and perspective taking","volume":"29","author":"Wells","year":"1998","journal-title":"Behav Ther"},{"issue":"7","key":"10.1002\/da.22047-BIB0012|da22047-cit-0012","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.janxdis.2010.04.007","article-title":"The moderated effects of video feedback for social anxiety disorder","volume":"24","author":"Rodebaugh","year":"2010","journal-title":"J Anxiety Disord"},{"issue":"3","key":"10.1002\/da.22047-BIB0013|da22047-cit-0013","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/S0005-7894(02)80035-1","article-title":"Treatment context and return of fear in spider phobia","volume":"33","author":"Mystkowski","year":"2002","journal-title":"Behav Ther"},{"issue":"2","key":"10.1002\/da.22047-BIB0014|da22047-cit-0014","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1037\/0022-006X.71.2.243","article-title":"Changes in caffeine states enhance return of fear in spider phobia","volume":"71","author":"Mystkowski","year":"2003","journal-title":"J Consult Clin Psychol"},{"issue":"6","key":"10.1002\/da.22047-BIB0015|da22047-cit-0015","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.jpsychires.2006.05.006","article-title":"A randomized controlled trial of the effect of D-Cycloserine on exposure therapy for spider fear","volume":"41","author":"Guastella","year":"2007","journal-title":"J Psychiatr Res"},{"issue":"6","key":"10.1002\/da.22047-BIB0016|da22047-cit-0016","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1001\/archpsyc.62.6.593","article-title":"Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey replication","volume":"62","author":"Kessler","year":"2005","journal-title":"Arch Gen Psychiatry"},{"key":"10.1002\/da.22047-BIB0017|da22047-cit-0017","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1017\/S0033291707001699","article-title":"Social fears and social phobia in the USA: results from the National Comorbidity Survey replication","volume":"38","author":"Ruscio","year":"2008","journal-title":"Psychol Med"},{"issue":"2","key":"10.1002\/da.22047-BIB0018|da22047-cit-0018","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1001\/archpsyc.1996.01830020087010","article-title":"Public speaking fears in a community sample: prevalence, impact on functioning, and diagnostic classification","volume":"53","author":"Stein","year":"1996","journal-title":"Arch Gen Psychiatry"},{"issue":"7","key":"10.1002\/da.22047-BIB0019|da22047-cit-0019","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.brat.2010.03.007","article-title":"Need for speed: evaluating slopes of OCD recovery in behavior therapy enhanced with D-Cycloserine","volume":"48","author":"Chasson","year":"2010","journal-title":"Behav Res Ther"},{"key":"10.1002\/da.22047-BIB0020|da22047-cit-0020","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1037\/0022-006X.71.6.1058","article-title":"Cognitive therapy vs fluoxetine in generalized social phobia: a randomized placebo controlled trial","volume":"71","author":"Clark","year":"2003","journal-title":"J Consult Clin Psychol"},{"key":"10.1002\/da.22047-BIB0021|da22047-cit-0021","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1001\/archpsyc.55.12.1133","article-title":"Cognitive-behavioral group therapy vs phenelzine therapy for social phobia: 12-week outcome","volume":"55","author":"Heimberg","year":"1998","journal-title":"Arch Gen Psychiatry"},{"issue":"Suppl 20","key":"10.1002\/da.22047-BIB0022|da22047-cit-0022","first-page":"22","article-title":"The Mini-International Neuropsychiatric Interview (M.I.N.I): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10","volume":"59","author":"Sheehan","year":"1998","journal-title":"J Clin Psychiatry"},{"issue":"6","key":"10.1002\/da.22047-BIB0023|da22047-cit-0023","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/S0887-6185(02)00134-2","article-title":"Screening for social anxiety disorder in the clinical setting: using the Liebowitz Social Anxiety Scale","volume":"16","author":"Mennin","year":"2002","journal-title":"J Anxiety Disord"},{"key":"10.1002\/da.22047-BIB0024|da22047-cit-0024","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1159\/000414022","article-title":"Social phobia","volume":"22","author":"Liebowitz","year":"1987","journal-title":"Mod Probl Pharmacopsychiatry"},{"key":"10.1002\/da.22047-BIB0025|da22047-cit-0025","first-page":"455","volume-title":"Dictionary of Behavioral Assessment Techniques","author":"Wolpe","year":"1988"},{"key":"10.1002\/da.22047-BIB0026|da22047-cit-0026","volume-title":"Managing Social Anxiety: A Cognitive-Behavioral Therapy Approach","author":"Hope","year":"2006"},{"key":"10.1002\/da.22047-BIB0027|da22047-cit-0027","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/S0005-7967(97)10031-6","article-title":"Development and validation of measures of social phobia scrutiny fear and social interaction anxiety","volume":"36","author":"Mattick","year":"1998","journal-title":"Behav Res Ther"},{"key":"10.1002\/da.22047-BIB0028|da22047-cit-0028","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1037\/0021-843X.110.1.40","article-title":"Misunderstanding analysis of covariance","volume":"110","author":"Miller","year":"2001","journal-title":"J Abnorm Psychol"},{"issue":"4","key":"10.1002\/da.22047-BIB0029|da22047-cit-0029","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1111\/j.1476-5381.2010.01175.x","article-title":"Pharmacological enhancement of fear reduction: preclinical models","volume":"164","author":"Graham","year":"2011","journal-title":"Br J Pharmacol"},{"issue":"2","key":"10.1002\/da.22047-BIB0030|da22047-cit-0030","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/nrd3628","article-title":"Cognitive dysfunction in psychiatric disorders: characteristics, causes and the quest for improved therapy. Nature reviews","volume":"11","author":"Millan","year":"2012","journal-title":"Drug Discov"},{"issue":"10","key":"10.1002\/da.22047-BIB0031|da22047-cit-0031","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1016\/j.biopsych.2007.04.010","article-title":"Effects of D-Cycloserine on extinction: consequences of prior exposure to imipramine","volume":"62","author":"Werner-Seidler","year":"2007","journal-title":"Biol Psychiatry"},{"issue":"11","key":"10.1002\/da.22047-BIB0032|da22047-cit-0032","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1101\/lm.1927310","article-title":"The effect of D-Cycloserine on immediate vs. delayed extinction of learned fear","volume":"17","author":"Langton","year":"2010","journal-title":"Learn Mem"},{"issue":"1","key":"10.1002\/da.22047-BIB0033|da22047-cit-0033","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1093\/cercor\/bhn076","article-title":"The NMDA agonist D-Cycloserine facilitates fear memory consolidation in humans","volume":"19","author":"Kalisch","year":"2009","journal-title":"Cereb Cortex"},{"issue":"5","key":"10.1002\/da.22047-BIB0034|da22047-cit-0034","doi-asserted-by":"crossref","first-page":"593","DOI":"10.4088\/JCP.09com05581whi","article-title":"Two clinical trial designs to examine personalized treatments for psychiatric disorders","volume":"72","author":"Leon","year":"2011","journal-title":"J Clin Psychiatry"}],"container-title":["Depression and Anxiety"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fda.22047","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1002\/da.22047\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,20]],"date-time":"2022-12-20T13:06:37Z","timestamp":1671541597000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/da.22047"}},"subtitle":["Research Article: A High-Throughput Clinical Assay"],"short-title":[],"issued":{"date-parts":[[2013,1,2]]},"references-count":34,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2013,7]]}},"URL":"https:\/\/doi.org\/10.1002\/da.22047","relation":{},"ISSN":["1091-4269"],"issn-type":[{"value":"1091-4269","type":"print"}],"subject":[],"published":{"date-parts":[[2013,1,2]]}}}